On July 13th, 2023, the Food and Drug Administration (FDA) approved Opill, a progestin-only birth control pill, for over-the-counter sale. The United States will now join over 100 countries where birth control pills are available without a prescription. Victoria Nichols, Project Director with Free the Pill, sits down to talk to us about what this approval means for birth control equity and access for those in the US.
Read More